0001209191-19-047421.txt : 20190826 0001209191-19-047421.hdr.sgml : 20190826 20190826170705 ACCESSION NUMBER: 0001209191-19-047421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190822 FILED AS OF DATE: 20190826 DATE AS OF CHANGE: 20190826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klencke Barbara CENTRAL INDEX KEY: 0001647647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37490 FILM NUMBER: 191053579 MAIL ADDRESS: STREET 1: C/O PRONAI THERAPEUTICS, INC. STREET 2: 2150 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sierra Oncology, Inc. CENTRAL INDEX KEY: 0001290149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 604-558-6536 MAIL ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FORMER COMPANY: FORMER CONFORMED NAME: ProNAi Therapeutics Inc DATE OF NAME CHANGE: 20040513 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-22 0 0001290149 Sierra Oncology, Inc. SRRA 0001647647 Klencke Barbara C/O SIERRA ONCOLOGY, INC. 2150 885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Development Officer Common Stock 2019-08-22 4 P 0 67000 0.4323 A 67000 I By spouse Common Stock 2019-08-22 4 P 0 54000 0.4499 A 54000 D Common Stock 2019-08-23 4 P 0 108000 0.4387 A 162000 D Represents the weighted average purchase price. The lowest price at which shares were purchased was $0.4375 and the highest price at which shares were purchased was $0.4399. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the range set forth herein. /s/ Sukhi Jagpal as attorney-in-fact for Barbara Klencke, M.D. 2019-08-26